DEDC, a new flavonoid induces apoptosis via a ROS-dependent mechanism in human neuroblastoma SH-SY5Y cells

Toxicology in Vitro

Volumn 26, Issue 1, 2012, Pages 16-23

  Liu, Huibin ^a   Jiang, Chunyang ^a   Xiong, Chaomei ^a   Ruan, Jinlan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Flavonoid; Neuroblastoma; NF B; ROS; STAT3

Indexed keywords

2 (CIS 1,2 DIHYDROXY 4 OXO CYCLOHEX 5 ENYL) 5,7 DIHYDROXYCHROMONE; ACETYLCYSTEINE; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL ACTIVITY; CELL DEATH; CELL LINE; CELL STRAIN SH SY5Y; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; SIGNAL TRANSDUCTION;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOHEXANONES; FLAVONES; HUMANS; NEUROBLASTOMA; NF-KAPPA B; PYRROLIDINES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; THIOCARBAMATES; TUMOR SUPPRESSOR PROTEIN P53;

MACROTHELYPTERIS TORRESIANA;

EID: 84855339789     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.10.002     Document Type: Article

References (37)

1. Aggarwal B.B., Sethi G., Ahn K.S., Sandur S.K., Pandey M.K., Kunnuma-kkara A.B., et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 2006, 1091:151-169.
2. Bauerle P.A., Baltimore D. NF-κB: ten years after. Cell 1996, 87:13-20.
3. Bollrath J., Phesse T.J., von Burstin V.A., Putoczki T., Bennecke M., Bateman T., et al. Gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009, 15:91-102.
4. Cathcart R., Schwiens E., Ames B.N. Detection of picomole levels of hydroperoxides using fluorescent dichlorofluorescein assay. Ann Biochem 1983, 134:111-116.
5. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
6. Das A., Banik N.L., Ray S.K. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer 2006, 119:2575-2585.
7. Datta N.S., Long M.W. Modulation of MDM2/p53 and Cyclin-activating kinase during the megakaryocyte differentiation of human erythroleukemia cells. Exp Hematol 2002, 30:158-165.
8. Egan L.J., Eckmann L., Greten F.R., Chae S., Li Z.W., Myhre G.M., et al. IkappaB-kinase-beta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci U S A 2004, 101:2452-2457.
9. Fennell D.A., Corbo M., Pallaska A., Cotter F.E. Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. Br J Cancer 2001, 10:1397-1404.
10. Fuster J.J., Sanz-González S.M., Moll U.M., Andrés V. Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med 2007, 13:192-199.
11. Grivennikov S.L., Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010, 21:11-19.
12. Hall M., Peters G. Genetic alterations of Cyclins, Cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 1996, 68:67-108.
13. Hirsch T., Decaudin D., Susin S.A., Marchetti P., Larochette N., Resche-Rigon M., et al. PK11195, a ligand of the mitochondrial benzodiazpine receptor, facilitates the induction of apoptosis and reverses the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res 1998, 241:426-434.
14. Izbicka E., Izbicki T. Therapeutic strategies for the treatment of neuroblastoma. Curr Opin Investig Drugs 2005, 6:1200-1214.
15. Jelinek J., Rafferty J.A., Cmejla R., Hildinger M., Chinnasamy D., Lashford L.S., et al. A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic. Gene Ther 1999, 6:1489-1493.
16. Ji B.S., He L., Liu G.Q. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Life Sci 2005, 77:2221-2232.
17. Kardosh A., Blumenthal M., Wang W.J., et al. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther 2004, 3:55-62.
18. Karin M. NF-kB and cancer: mechanisms and targets. Mol Carcinog 2006, 45:355-361.
19. Karin M., Ben Neriah M. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000, 18:621-663.
20. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat Med 2000, 6:513-519.
21. Li X., Song L., Jope R.S. Cholinergic stimulation of AP-1 and NF kappaB transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. J Neurosci 1996, 16:5914-5922.
22. Liu H.B., Xiao Y.L., Xiong C.M., Wei A.H., Ruan J.L. Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation. Eur J Pharmacol 2011, 654:209-216.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
24. Manson M. Cancer prevention-the potential for diet to modulate molecular signaling. Trends Mol Med 2003, 9:11-18.
25. Middleton J.E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000, 52:673-751.
26. Niu G., Wright K.L., Ma Y., Wright G.M., Huang M., Irby R., et al. Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 2005, 25:7432-7440.
27. Read M.A., Brownell J.E., Gladysheva T.B. Nedd8 modification of cul-1 activates SCF(β(TrCP))-dependent ubiquitination of IκBα. Mol Cell Biol 2000, 20:2326-2333.
28. Simpson J.K., Gaze M.N. Current management of neuroblastoma. Oncologist 1998, 3:253-262.
29. van Noesel M.M., Versteeg R. Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 2004, 325:1-15.
30. Visconti R., Grieco D. New insights on oxidative stress in cancer. Curr Opin Drug Discov Devel 2009, 12:240-245.
31. Watson W., Cai J., Jones D. Diet and apoptosis. Annu Rev Nutr 2000, 108:153-164.
32. Xia Z., Lundgren B., Bergstrand A., DePierre J.W., Nassberger L. Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-XL. Biochem Pharmacol 1999, 57:1199-1208.
33. Yang C., Landau J., Huang M., Newmark H. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001, 21:381-397.
34. Yang, H.L., Chen, C.S., Chang, W.H., Lu, F.J., Lai, Y.C., Chen, C.C., et al., Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorate. Cancer Lett 231, 215-227.
35. Yu H., Jove R. The STATs of cancer-newmolecular targets come of age. Nat Rev Cancer 2004, 4:97-105.
36. Yue P., Turkson J. Targeting STAT3 in cancer: how successful are we?. Expert Opin Investig Drugs 2009, 18:45-56.
37. Zhong Z., Wen Z., Darnell J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264:95-98.